Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee

C. Chabannon; M. Hildebrandt; S. Scheding; A. Humpe; M. Lowdell; I. Slaper-Cortenbach

doi:10.1038/bmt.2014.271

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee

C. Chabannon
, M. Hildebrandt
, S. Scheding
, A. Humpe
, M. Lowdell
, I. Slaper-Cortenbach

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	321-323
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	50
Issue number	3
DOIs	https://doi.org/10.1038/bmt.2014.271
Publication status	Published - 1 Mar 2015

Access to Document

10.1038/bmt.2014.271

RegulationFinal published version, 247 KBLicence: Taverne

Cite this

@article{178beb050bdc408fa7d8f0f1ee9aa6a0,

title = "Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee",

author = "C. Chabannon and M. Hildebrandt and S. Scheding and A. Humpe and M. Lowdell and I. Slaper-Cortenbach",

year = "2015",

month = mar,

day = "1",

doi = "10.1038/bmt.2014.271",

language = "English",

volume = "50",

pages = "321--323",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "3",

}

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee. / Chabannon, C.; Hildebrandt, M.; Scheding, S. et al.
In: Bone Marrow Transplantation, Vol. 50, No. 3, 01.03.2015, p. 321-323.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future

T2 - A perspective from the EBMT cell-processing committee

AU - Chabannon, C.

AU - Hildebrandt, M.

AU - Scheding, S.

AU - Humpe, A.

AU - Lowdell, M.

AU - Slaper-Cortenbach, I.

PY - 2015/3/1

Y1 - 2015/3/1

UR - https://www.scopus.com/pages/publications/84938414967

U2 - 10.1038/bmt.2014.271

DO - 10.1038/bmt.2014.271

M3 - Editorial

C2 - 25501349

AN - SCOPUS:84938414967

SN - 0268-3369

VL - 50

SP - 321

EP - 323

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 3

ER -

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee

Access to Document

Other files and links

Cite this